Dietary proanthocyanidins modulate BMAL1 acetylation, Nampt expression and NAD levels in rat liver
Citations Over TimeTop 13% of 2015 papers
Abstract
Metabolism follows circadian rhythms, which are driven by peripheral clocks. Clock genes in the liver are entrained by daytime meals and food components. Proanthocyanidins (PAs), the most abundant flavonoids in the human diet, modulate lipid and glucose metabolism. The aim of this study was to determine whether PAs could adjust the clock system in the liver. Male Wistar rats were orally gavaged with 250 mg grape seed proanthocyanidin extract (GSPE)/kg body weight at zeitgeber time (ZT) 0 (light turned on), at ZT12 (light turned off), or before a 6 hour jet-lag and sacrificed at different times. The 24 hour rhythm of clock-core and clock-controlled gene expression indicated that nicotinamide phosphoribosyltransferase (Nampt) was the most sensitive gene to GSPE. However, Nampt was repressed or overexpressed after GSPE administration at ZT0 or ZT12, respectively. NAD levels, which are controlled by Nampt and also exhibit circadian rhythm, decreased or increased according to Nampt expression. Moreover, the ratio of acetylated Bmal1, that directly drives Nampt expression, only increased when GSPE was administered at ZT12. Therefore, GSPE modulated the clock system in the liver, suggesting that PAs can regulate lipid and glucose metabolism by adjusting the circadian rhythm in the liver.
Related Papers
- → Boosting NAD+ with a small molecule that activates NAMPT(2019)156 cited
- → Anticancer agent CHS-828 inhibits cellular synthesis of NAD(2008)116 cited
- → Quantitative analysis of the effects of nicotinamide phosphoribosyltransferase induction on the rates of NAD+ synthesis and breakdown in mammalian cells using stable isotope-labeling combined with mass spectrometry(2019)21 cited
- Nicotinamide phosphoribosyltransferase inhibitors in cancer therapy:an advance(2012)
- → Abstract 1871: Targeting nicotinamide phosphoribosyltransferase (NAMPT) in cancer therapy.(2013)